Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 30, 2021
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
Thu, July 29, 2021
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
[ Thu, Jul 29th 2021
] - WOPRAI
Kennen MacKay Maintained (BMRN) at Hold with Increased Target to $88 on, Jul 29th, 2021
Kennen MacKay of RBC Capital, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Increased Target from $87 to $88 on, Jul 29th, 2021.
Kennen has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, all agrees with Kennen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $82 on, Monday, April 19th, 2021
